scholarly article | Q13442814 |
P2093 | author name string | Lai ST | |
Zhang JZ | |||
Ng MH | |||
Xia NS | |||
Lau SH | |||
Im SW | |||
Chau TN | |||
Che XY | |||
P2860 | cites work | Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase | Q27860571 |
Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome | Q33415661 | ||
Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986–1988) of China | Q35073690 | ||
Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). | Q41101945 | ||
ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates | Q41537344 | ||
Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes | Q41632254 | ||
Immunodominant antigenic regions in a structural protein of the hepatitis E virus | Q42610428 | ||
Sequence and gene structure of the hepatitis E virus isolated from Myanmar | Q42621387 | ||
Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates | Q43410896 | ||
Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are masked. | Q44922261 | ||
Epitope Mapping in Proteins of Hepatitis E Virus | Q45786970 | ||
Virus of enterically transmitted non-A, non-B hepatitis | Q45839816 | ||
Enterically transmitted non-A, non-B hepatitis: recovery of virus-like particles from an epidemic in south Delhi and transmission studies in rhesus monkeys | Q45846726 | ||
Hepatitis E | Q64135773 | ||
P433 | issue | 2 | |
P921 | main subject | hepatitis E | Q326643 |
hepatitis E virus | Q5731737 | ||
P304 | page(s) | 125-132 | |
P577 | publication date | 2001-06-01 | |
P1433 | published in | Journal of Medical Virology | Q15716684 |
P1476 | title | Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein | |
P478 | volume | 64 |
Q51525883 | A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. |
Q43631931 | A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus |
Q33788163 | A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice |
Q35331616 | A valuable antigen detection method for diagnosis of acute hepatitis E. |
Q38329067 | Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. |
Q36973372 | Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy. |
Q42222473 | Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes |
Q51733616 | Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro. |
Q43168143 | Classification of human and zoonotic group hepatitis E virus (HEV) using antigen detection |
Q38048600 | Diagnosis of hepatitis E. |
Q27656916 | Dimerization of Hepatitis E Virus Capsid Protein E2s Domain Is Essential for Virus–Host Interaction |
Q28072683 | Epidemiology of Hepatitis E in Pregnant Women and Children in Iran: A General Overview |
Q89965385 | Expression, Purification and Characterization of the Hepatitis E Virus Like-Particles in the Pichia pastoris |
Q34151626 | HEV-Capsid Protein Interacts With Cytochrome P4502C8 and Retinol-Binding Protein 4. |
Q37278231 | Hepatitis E vaccine |
Q54334450 | Hepatitis E vaccine development: a 14 year odyssey. |
Q35826279 | Hepatitis E vaccines: progress and prospects |
Q36678270 | Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts |
Q38917141 | Hepatitis E virus enters liver cells through a dynamin-2, clathrin and membrane cholesterol-dependent pathway |
Q33517634 | Hepatitis E virus infection in central China reveals no evidence of cross-species transmission between human and swine in this area. |
Q33711694 | Hepatitis E virus serosurvey among pet dogs and cats in several developed cities in China |
Q37375936 | Hepatitis E virus: Current epidemiology and vaccine |
Q37613164 | Hepatitis e: molecular virology and pathogenesis |
Q40507410 | Laboratory Diagnosis of HEV Infection |
Q27013018 | Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins |
Q34166393 | Molecular virology of hepatitis E virus |
Q42470891 | Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. |
Q45091646 | Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitis |
Q40035451 | Production and characterization of a Brazilian candidate antigen for Hepatitis E Virus genotype 3 diagnosis. |
Q40507392 | Prophylactic Hepatitis E Vaccine |
Q92808828 | Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation |
Q83235565 | Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine |
Q42212470 | Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®). |
Q33203193 | Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology |
Q37894294 | Serological diagnostics of hepatitis E virus infection |
Q33868335 | Significance of serum IgA in patients with acute hepatitis E virus infection |
Q37881208 | Toward the development of a hepatitis E vaccine |
Q51708777 | Transfusion of plasma from a blood donor induced hepatitis E in Rhesus monkey. |
Search more.